PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Royal DSM N.V.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DSM and Republic of Tatarstan Sign MoU for Fortified Nutrition - Royal DSM announces that it has signed a Memorandum of Understanding for a strategic partnership with the Ministry of Health Care of the Republic of Tatarstan - Tatar.ru / DSM.com
DSM and Republic of Tatarstan Sign MoU for Fortified Nutrition

 

NewswireToday - /newswire/ - Heerlen, Netherlands, 2013/04/08 - Royal DSM announces that it has signed a Memorandum of Understanding for a strategic partnership with the Ministry of Health Care of the Republic of Tatarstan - Tatar.ru / DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with the Ministry of Health Care of the Republic of Tatarstan with the aim of modernizing the Republic’s public health sector through fortified nutrition. The MOU was signed today in Amsterdam (Netherlands) in the presence of President Vladimir Putin of the Russian Federation and Prime Minister Mark Rutte of the Netherlands.

Under the terms of the MOU, DSM and the Ministry of Health Care of the Republic of Tatarstan (tatar.ru) will implement a study for the provision of vitamins to patients (children and adults) admitted for treatment to in-patient hospitals to measure the effectiveness of a specially developed vitamin and mineral complex. Following a positive outcome, the objective is to start adding vitamins/minerals when providing in-patient medical care in hospitals in the Republic of Tatarstan.

The strategic partnership between DSM and the Republic of Tatarstan has been developed within the framework of cooperation between the Russian Federation and the Netherlands. The Russian Federation’s Healthy Nutrition strategy for 2020 aims at preserving and strengthening public health and preventing of nutrition related diseases. It has been concluded that based on the current demographic situation in the Russian Federation, a change in nutrition patterns is needed to increase the life expectancy of the Russian population.

Rustam Minnikhanov, President of the Republic of Tatarstan, said: “On behalf of the Republic of Tatarstan I fully support DSM in its efforts to further develop its successful cooperation that started in 2010 in Naberezhnye Chelny with the production of animal nutrition. Full and regular supply of the body with vitamins, minerals and trace elements is one of the key factors in maintaining health. This joint project of DSM, the Institute of Nutrition and the Ministry of Health will enable the introduction of preventive fortification as a standard provision of medical assistance in the hospitals of the Republic.”

Feike Sijbesma, Chief Executive Officer and Chairman of the DSM Managing Board, said: “As the world’s largest producer of micronutrients, DSM has the expertise and resources needed to support an effective governmental food fortification program. An insufficient vitamin A intake can have a negative effect on the efficiency of hospital treatment, but also lowers patients’ resistance. I am proud that we will work with the Ministry of Health Care in Tatarstan to begin to reduce vitamin deficiencies and subsequently increase life expectancy and I hope we will be able to expand this initiative to other regions of the Russian Federation.”

For DSM, Russia is one of the High Growth Economies the company is focusing on in executing its strategy DSM in motion: driving focused growth. DSM’s main business areas in Russia are food and feed ingredients, pharmaceutical intermediate products, biotechnology, UHMWPE-based materials, resins and engineering plastics. Through its business activities, DSM meets the needs and trends in the Russian Federation. In 2012, DSM celebrated 20 years of presence in Russia.

In 2010 DSM (dsm.com) started a joint venture in Tatarstan to contribute to Russia’s goal of reaching a higher self-sufficiency in animal protein production and supply by securing better animal nutrition. In 2011 DSM entered into a long-term partnership in the area of engineering plastics with JSC KuibyshevAzot in Tolyatti (Samara Region) in order to supply locally produced products to the automotive and electrical & electronics industries.

DSM Investor Relations
Dave Huizing
P: +31 (0)45 578 2864 - E: investor.relations[.]dsm.com.

Ministry of Health Care of the Republic of Tatarstan
P: +7 843 231 79 98 - E: minzdrav[.]tatar.ru.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DSM and Republic of Tatarstan Sign MoU for Fortified Nutrition

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Royal DSM N.V. | Republic of Tatarstan
Publisher Contact: Herman Betten - DSM.com 
+31(0)45 5782017 media.relations[.]dsm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Royal DSM N.V. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)